Now showing items 1-3 of 3

    • Erratum to: practical approach to initiating SGLT2 inhibitors in type 2 diabetes 

      Gomez-Peralta, Fernando; Abreu, Cristina; Lecube Torelló, Albert; Bellido, Diego; Soto, Alfonso; Morales, Cristóbal; Brito-Sanfiel, Miguel; Umpierrez, Guillermo (Springer Verlag, 2017)
      Erratum to: practical approach to initiating SGLT2 inhibitors in type 2 diabetes.
    • Global assessment of the impact of type 2 diabetes on sleep through specific questionnaires. A case-control study 

      Lecube Torelló, Albert; Sánchez Peña, Enric; Gómez Peralta, Fernando; Abreu, Cristina; Valls Marsal, Joan; Mestre, Olga; Romero, Odile; Martínez González, María Dolores; Sampol, Gabriel; Ciudin, Andreea; Hernández, Cristina; Simó, Rafael (Public Library of Science, 2016)
      Type 2 diabetes (T2D) is an independent risk factor for sleep breathing disorders. However, it is unknown whether T2D affects daily somnolence and quality of sleep independently of the impairment of polysomnographic ...
    • Practical approach to initiating SGLT2 inhibitors in type 2 diabetes 

      Gomez-Peralta, Fernando; Abreu, Cristina; Lecube Torelló, Albert; Bellido, Diego; Soto, Alfonso; Morales, Cristóbal; Brito-Sanfiel, Miguel; Umpierrez, Guillermo (Springer Verlag, 2017)
      Sodium-glucose co-transporter 2 (SGLT2) inhibitors are an attractive novel therapeutic option for the treatment of type 2 diabetes. They block the reabsorption of filtered glucose in kidneys, mainly in proximal renal ...